NO20004880L - Use of inhibitors of retinoic acid activity to reduce hair loss - Google Patents

Use of inhibitors of retinoic acid activity to reduce hair loss

Info

Publication number
NO20004880L
NO20004880L NO20004880A NO20004880A NO20004880L NO 20004880 L NO20004880 L NO 20004880L NO 20004880 A NO20004880 A NO 20004880A NO 20004880 A NO20004880 A NO 20004880A NO 20004880 L NO20004880 L NO 20004880L
Authority
NO
Norway
Prior art keywords
hair loss
retinoic acid
inhibitors
acid activity
reduce hair
Prior art date
Application number
NO20004880A
Other languages
Norwegian (no)
Other versions
NO20004880D0 (en
Inventor
Jean-Daniel Doutremepuich
Carole Marconnet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO20004880D0 publication Critical patent/NO20004880D0/en
Publication of NO20004880L publication Critical patent/NO20004880L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Oppfinnelsen vedrører anvendelse i eller for fremstilling av et kosmetisk eller farmasøytisk preparat, foretrukket dermatologisk, av minst en inhibitor av aktiviteten av retinsyre, idet preparatet er utformet til å nedsette eller hindre vekst av hår og/eller håret. Preparatet er også utformet til å nedsette tap av hår og/eller håret.The invention relates to the use in or for the preparation of a cosmetic or pharmaceutical composition, preferably dermatologically, of at least one inhibitor of the activity of retinoic acid, the composition being designed to reduce or prevent hair and / or hair growth. The preparation is also designed to reduce hair loss and / or hair loss.

NO20004880A 1998-03-31 2000-09-28 Use of inhibitors of retinoic acid activity to reduce hair loss NO20004880L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (en) 1998-03-31 1998-03-31 USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY
PCT/FR1999/000687 WO1999049838A1 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss

Publications (2)

Publication Number Publication Date
NO20004880D0 NO20004880D0 (en) 2000-09-28
NO20004880L true NO20004880L (en) 2000-11-30

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004880A NO20004880L (en) 1998-03-31 2000-09-28 Use of inhibitors of retinoic acid activity to reduce hair loss

Country Status (16)

Country Link
EP (1) EP1066017A1 (en)
JP (1) JP2002509870A (en)
KR (1) KR20010042104A (en)
CN (1) CN1298290A (en)
AR (1) AR015551A1 (en)
AU (1) AU2938899A (en)
BR (1) BR9908411A (en)
CA (1) CA2324899A1 (en)
FR (1) FR2776511B1 (en)
HU (1) HUP0102411A3 (en)
IL (1) IL137859A0 (en)
NO (1) NO20004880L (en)
PL (1) PL343004A1 (en)
RU (1) RU2193877C2 (en)
WO (1) WO1999049838A1 (en)
ZA (1) ZA200004483B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (en) * 1995-05-03 1997-05-30 Cird Galderma USE OF RETINOIDS IN A COSMETIC COMPOSITION OR FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION
FR2739777B1 (en) * 1995-10-11 1997-11-14 Cird Galderma LIGAND ANTAGONIST RAR-GAMMA OR AGONIST RAR-ALPHA AS AN APOPTOSIS INHIBITOR
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6121309A (en) * 1996-03-18 2000-09-19 Eisai Co., Ltd. Fused-ring carboxylic acid derivatives

Also Published As

Publication number Publication date
NO20004880D0 (en) 2000-09-28
HUP0102411A3 (en) 2002-12-28
HUP0102411A2 (en) 2001-11-28
EP1066017A1 (en) 2001-01-10
FR2776511B1 (en) 2001-05-11
WO1999049838A1 (en) 1999-10-07
RU2193877C2 (en) 2002-12-10
AR015551A1 (en) 2001-05-02
BR9908411A (en) 2000-12-05
CN1298290A (en) 2001-06-06
PL343004A1 (en) 2001-07-30
KR20010042104A (en) 2001-05-25
IL137859A0 (en) 2001-10-31
FR2776511A1 (en) 1999-10-01
CA2324899A1 (en) 1999-10-07
JP2002509870A (en) 2002-04-02
AU2938899A (en) 1999-10-18
ZA200004483B (en) 2002-02-27

Similar Documents

Publication Publication Date Title
NO20005265L (en) Substituted benzamides, their preparation and use as inhibitors of cystine proteases
CA2241981A1 (en) Method of inhibiting photoaging of skin
BR9909248A (en) Enzyme inhibitors
DE60115618D1 (en) USE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS CONTAINING 2-DECARBOXY-2-PHOSPHINO PROSTAGLANDINE DERIVATIVES
ATE254443T1 (en) INHIBITING HAIR GROWTH
FI973492A (en) NO synthase inhibitors
WO2003002114A3 (en) Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
NO20005161D0 (en) N, N-disubstituted amides which inhibit the binding of integrins to their receptors
NO20010844L (en) Regulation of substrate activity
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
MXPA04004479A (en) Topical compositions containing enzymes stabilized with inhibitors.
BR9811099A (en) Urokinase inhibitors
DK1363608T3 (en) Formulations comprising ibuprofen and diphenhydramine and their use in the treatment of sleep disorders
DK0755249T3 (en) Use of Maillard reaction inhibitor to treat amyloidosis-based disease
DE60014369D1 (en) PROPANIC ACID DERIVATIVES THAT INHIBIT INTEGRINE BINDING TO THEIR RECEPTORS
WO2003035050A3 (en) Use of tyrosine kinase inhibitors for promoting hair growth
DK0888327T3 (en) Benzopyran derivatives which have antagonistic action against leukotrienes
NO20002479L (en) Combination of angiotensin converting enzyme inhibitor and a diuretic for the treatment of microcirculatory disorders
WO2003002107A3 (en) Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)
DK0700898T3 (en) L-carnitine salt and cosmetic and pharmaceutical preparations containing the same, for the treatment of dermatoses.
WO2003002105A3 (en) Use of tyrosine kinase inhibitors for treating bone loss
GB8925833D0 (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
ATE234359T1 (en) FUSION PROTEINS CONSISTING OF TISSUE FACTOR KUNITZDOMAIN AS INHIBITORS OF FACTOR VIIA
ES2137125A1 (en) Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt.
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.